Researchers diving into a real-world Polish diabetes registry have pinpointed three distinct patient groups that reveal why diabetes hits people so differently when it comes to heart risks.
The study published in the Diabetes Medicine pulled data from 2109 participants with a median age of 60 years—half men—and used hierarchical cluster analysis on 19 key factors like comorbidities and cardiovascular risks. Their main goal was to link these groups to major adverse cardiovascular events, or MACEs, which include heart-related death, acute coronary issues, revascularizations, strokes, new heart failure, and hospital stays for heart problems. They also tracked each MACE and overall death rates. 
Spotting the Three Key Clusters
The analysis determined three clear phenotypes from the diverse group. Cluster 1 made up 27.8%—younger folks mostly with type 1 diabetes. Cluster 2, the largest at 42%, featured elderly type 2 patients loaded with multiple health issues. Cluster 3 held 30.2%, middle-aged type 2 patients with higher cardiometabolic risks like obesity and high cholesterol.
Heart Risks Vary Sharply by Group
When comparing heart event risks, cluster 1 came out safest. Compared to them, cluster 2 patients faced nearly three times higher MACE odds after adjustments, with a hazard ratio of 2.93 and confidence interval from 1.60 to 5.36. Cluster 3 risk was 1.85 times higher, between 1.07 and 3.20. Switching views with cluster 3 as baseline, cluster 1 showed protective effects at 0.54 odds from 0.31 to 0.94, while cluster 2 risk climbed to 1.58 from 1.08 to 2.33. 
Why Phenotypes Matter for Doctors
These findings stress diabetes as a multifaceted condition needing customized care over blanket treatments. Young type 1 patients in cluster 1 might require tight insulin control and basic monitoring. Middle-aged cluster 3 individuals require aggressive lipid and weight management to curb cardiometabolic threats. Elderly cluster 2 demands full-spectrum care to minimize MACE burdens. For physicians, this means routine phenotyping through simple risk profiling to prioritize interventions, potentially saving lives and reducing hospital stays in this high-stakes population.